China’s regional inequity in pharmacist’s drug safety practice
- Liyang Tang
- … show all 1 hide
The promotion of patient safety and drug safety through promotion of pharmacist’s drug safety practice was among the most important aims of China’s health delivery system reform, but regional inequity in pharmacist’s drug safety practice was still serious in China.
The 2011 national patient safety and medication error baseline survey was carried out for the first time in China, and through analyzing dataset from the survey, this study was set up to test both China’s regional inequity in pharmacist’s drug safety practice and major influencing factors for pharmacist’s drug safety practice among different districts of China.
Pharmacist’s drug safety practice in regions with higher per capita GDP and more abundant medical resources was still better than that in regions with lower per capita GDP and less abundant medical resources. In all districts of China, pharmacist’s drug safety knowledge, drug safety attitude, self-perceived pressure and fatigue, hospital management quality, and hospital regulation were major influencing factors for pharmacist’s drug safety practice, while only in regions with higher per capita GDP and more abundant medical resources, hospital drug safety culture, supervisor’s work team management, cooperation atmosphere of work team, and drug safety culture of work team were major influencing factors for pharmacist’s drug safety practice.
Regional inequity in pharmacist’s drug safety practice still existed in China. In all districts of China, promoting pharmacist’s drug safety knowledge, drug safety attitude, self-perceived pressure and fatigue, hospital management quality, and hospital regulation could help promote pharmacist’s drug safety practice, while only in regions with higher per capita GDP and more abundant medical resources, promoting hospital drug safety culture, supervisor’s work team management, cooperation atmosphere of work team, and drug safety culture of work team could help promote pharmacist’s drug safety practice. And in regions with lower per capita GDP and less abundant medical resources, the link between pharmacist’s drug safety practice and hospital drug safety culture/supervisor’s work team management/cooperation atmosphere of work team/drug safety culture of work team should also be gradually established.
- Du W, Guo JJ, Jing Y, Li X, Kelton CM: Drug safety surveillance in China and other countries: a review and comparison. Value Health 2008, 11:130–136. CrossRef
- State Food and Drug Administration of China: Drug administration law of the People’s Republic of China. http://www.sfda.gov.cn/WS01/CL0784/23396.html
- The network of ADRs monitoring in China. http://www.adr.gov.cn
- Center for Drug Re-evaluation. http://www.cdr.gov.cn
- The Ministry of Health, State Food and Drug Administration of China: Regulation for the administration of adverse drug reaction report and monitoring. http://www.sda.gov.cn/WS01/CL0053/24477.html
- Hou YL: ADR reports in China reached a new peak in 2005. China Pharm News 2006, Section A1:1.
- Chinese Medical Institute & Register: Code of conduct and good practice. http://www.cmir.org.uk/index.php?page=code-of-conduct-and-good-practice
- State Food and Drug Administration of China: Laws and regulations. http://www.sfda.gov.cn/WS01/CL0006/
- The pharmacy department of Peking University Third Hospital: Report on patient safety, drug safety and medication error in China. Beijing: Peking University Third Hospital; 2011.
- Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M: Tackling the challenges to health equity in China. Lancet 2008, 372:1493–1501. CrossRef
- Feng X, Tang S, Bloom G, Segall M, Gu Y: Cooperative medical schemes in contemporary rural China. Soc Sci & Med 1995, 41:1111–1118. CrossRef
- Liu Y, Hu S, Fu W, Hsiao WC: Is community financing necessary and feasible for rural China? Health Policy 1996, 38:155–171. CrossRef
- Liu Y, Hsiao WC, Eggleston K: Equity in health and health care: the Chinese experience. Soc Sci & Med 1999, 49:1349–1356. CrossRef
- Liu Y, Rao K, Hsiao WC: Medical expenditure and rural impoverishment in China. J Health Popul Nutr 2003, 21:216–222.
- World Bank: China’s health sector-why reform is needed. Washington, DC: World Bank; 2005.
- Vincent C, Taylor-Adams S, Stanhope N: Framework for analyzing risk and safety in cultural medicine. BMJ 1998, 316:1154–1157. CrossRef
- Vincent C, Stanhope N, Crowley-Murphy M: Reasons for not reporting adverse incidents: an empirical study. J Eval Clin Pract 1999,5(1):13–21. CrossRef
- Vincent C, Neale G, Woloshynowych M: Adverse events in British hospitals: preliminary retrospective review. BMJ 2001, 322:517–519. CrossRef
- National Patient Safety Agency: Seven steps to patient safety. London: NPSA; 2003.
- World Health Organization: World alliance for patient safety. Geneva: WHO; 2004.
- Liu Y, Rao K, Wu J, Gakidou E: China’s health system performance. Lancet 2008, 372:1914–1923. CrossRef
- Liu Y: Reforming China’s health care: for the people, by the people? Lancet 2009, 373:281–283. CrossRef
- Qiu Y, Liu P, Xu M: Effective regulation measures for hospital drug safety. China Pharmacist 2002,5(9):538–539.
- Jia C, Dong S, Yang Y: Strengthening drug management and ensuring the safety and effectiveness of medication. China Pharmacist 2005,8(2):151–152.
- Mei D, Tang Y, Liu M: Pharmacist and medication safety. Adverse Drug Reactions J 2005,7(1):7–10.
- Shao M: Guaranteeing public drug safety, and promoting the availability of drugs-drug policy issues in China. Chinese Pharmaceutical Affairs 2005,19(8):451–456.
- Song J: Current situation of pharmaceutical management in basic level medical institutions and improving measures. Chinese Pharmaceutical Affairs 2006,20(2):75–76.
- Chen S, Kuai L: The concept and practice of national drug policy. J Pharmaceutical Prac 2007,25(5):348–351.
- Dong X: Strengthen the ADR monitoring and improve the level of safety used drug. Chinese Pharmaceutical Affairs 2008,22(9):779–780.
- Jiang Y, Wang Z: Risks of and recommendations for drug safety in primary health care institutions. Chinese J Hospital Pharmacy 2008,28(19):1709–1730.
- Wang Y: Analysis of how to do best in current food and drug administration. Chinese Pharmaceutical Affairs 2008,22(2):93–95.
- Wang X, Zhang B, Zhang M, Wang Z: Preventing drug safety problems and guaranteeing public drug safety. J Changchun University of Traditional Chinese Medicine 2008,24(6):673–674.
- Wu X, Chen Y: Functions and roles of pharmacists in drug safety practice. Contemporary Med 2008, 5:37–38.
- Jiang B, Chen J, Yan Y, Shi L: A preliminary study on drug safety in China. Chinese J Pharmacentical Technolgy Economics & Management 2009,3(10):81–84.
- Ren X, Tang J: Exploring the implementation of hospital pharmacist responsibility system. China Pharmacist 2009,12(10):1484–1485.
- Ruan J: Pharmacist’s intervention for drug management in clinical departments. Herald of Medicine 2009,28(8):1100–1101.
- Wang F: Drug safety issues and management strategies. Strait Pharmaceutical J 2010,22(8):286–262.
- Xie X, Wang M: Hospital drug management status and recommendations for drug management improvement. China Modern Med 2010,17(31):138–141.
- Chu C, Wang Y, Fu P, Bai Z: Clinical departments should pay attention to drug management and hidden drug safety problems, and continuously improve related measures. Chinese J Ethnomedicine and Ethnopharmacy 2011,20(1):195.
- Agency for Healthcare Research and Quality: Hospital survey on patient safety culture. Rockville: Agency for Healthcare Research and Quality; 2011.
- China’s regional inequity in pharmacist’s drug safety practice
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
International Journal for Equity in Health
- Online Date
- August 2012
- Online ISSN
- BioMed Central
- Additional Links
- Liyang Tang (1)
- Author Affiliations
- 1. Department of Economics, School of Economics and Management, Tsinghua University, Beijing, 100084, China